chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine; Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BELL'S PALSY (Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine) (seriousness criterion medically significant) and RASH (Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine). At the time of the report, BELL'S PALSY (Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine) and RASH (Seen on Reddit that others experienced rash and Bells Palsy after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.  Company Comment: This case concerns a patient of an unknown age and gender with no relevant medical history, who experienced the expected event of Bell's Palsy. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 Vaccine. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2021-386032 (Patient Link).; Sender's Comments: This case concerns a patient of an unknown age and gender with no relevant medical history, who experienced the expected event of Bell's Palsy. The event occurred on an unknown date after receiving an unknown dose number of mRNA-1273 Vaccine. The event is consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Pt said she acquired an infection at the site of injection. She went to a MD who said it was an infection at that site. Pt received antibiotics for it. Per pt warm to touch at site & a little bump.
Case number PHEH2014US022358 is an initial spontaneous report from the nurse received on 06 Nov 2014. This report refers to a 18-months-old female patient who was inadvertently vaccinated with 0.25 ml of FLUVIRIN (batch number: 1413201) intramuscularly on 05 Nov 2014. No adverse event reported following this medication error (inappropriate age at vaccine administration).
About 15 minutes after recievieng the vaccine I developed hives on my hands and arms, feet and legs.  I also had some swelling of my lip and some mild chest tightness.  I was treated with oral Pepcid and Oral Zyrtec.  My hives resolved after about 15 minutes as did my mild chest tightness.  I was observed for an hour.    Later that evening about 8, my face and lip began to swell, I had significant chest tightness, with severe coughing and wheezing.  I also had hives again on my hands, neck and face.  I used my Epipen and albuterol inhaler.  My chest was still very tight and my cough was very bad.  I went to the emergency room.  I was given DuoNeb, Pepcid, Benedryl, and Prednisone.  They were unable to start an IV so gave me oral medications.  Over the next hour my symptoms resolved and I felt much better.  I was discharged about midnight.    Today I have a very sore throat from coughing so much and my body is very achy and I have diarrhea.  I have had this same issue however the last time I needed to use Epi when I accidentally ate Shrimp.
while shot was being administered-muscles in arm started jumping rapidly-slowing to flutter-nausea,arm hurt,extreme cold-hands tingling;felt like about to pass out-UNCONTROLLABLE chills 20-30 min recovered;does not feel well;02 thin,nausea;
Adverse events: Morning of 1/7/2021, vaccine site started itching and got small hives, then throughout the day turned red, developed a hard mass, and became hot. Treatment: currently taking 600 mg of ibuprofen 3x per day and using cold compresses for 2 days. Drew a circle around the infested site and monitoring. Prescribed cephalexin if symptoms worsen and told to return to urgent care or see my pcp if I have to start antibiotics and symptoms still continue to worsen Outcome: redness seems to be decreased this AM and maybe slight decrease in size. Will continue  with treatment course and address from there.
Left cervical painful lymphadenopathy, myalgias, arthralgias, chills, subjective fever, night sweats, headache from afternoon day of vaccine lasting for 18 hours.
experiencing severe reactions unlike her experience on the first dose; diarrhea on the same evening of her shot for 3-4 hrs; area around the injection site warm to touch.; body chills; 6-7 hrs after the 2nd shot, she experienced high fever - 103.7 F yesterday; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experiencing severe reactions unlike her experience on the first dose), DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs), INJECTION SITE WARMTH (area around the injection site warm to touch.), CHILLS (body chills) and PYREXIA (6-7 hrs after the 2nd shot, she experienced high fever - 103.7 F yesterday) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00ZAZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experiencing severe reactions unlike her experience on the first dose), DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs), INJECTION SITE WARMTH (area around the injection site warm to touch.), CHILLS (body chills) and PYREXIA (6-7 hrs after the 2nd shot, she experienced high fever - 103.7 F yesterday). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Chills, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (experiencing severe reactions unlike her experience on the first dose), DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs), INJECTION SITE WARMTH (area around the injection site warm to touch.), CHILLS (body chills) and PYREXIA (6-7 hrs after the 2nd shot, she experienced high fever - 103.7 F yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included PARACETAMOL (TYLENOL).
One of two patients who exp a total body rash & fever w/in 48 hrs p/immun & worsened by day 4; tx APAP;
He missed the dose of MENQUADFI with no adverse event; Initial information received on 24-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 2 years old male patient who missed the dose of Meningococcal A-C-Y-W135 (T CONJ) Vaccine [Menquadfi] with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient missed a dose of suspect Meningococcal A-C-Y-W135 (T CONJ) Vaccine Solution for injection (Expiry: 18-Apr-2024) (lot number, strength, dose not reported) via unknown route in unknown administration site as prophylactic vaccination with no adverse event (product dose omission issue) (Latency- same day).  It was reported "Her pediatric patient was meant to receive one dose each of MENQUADFI and YF-VAX. However, the patient received one dose of TYPHIM-VI and two doses of YF-VAX. He missed the dose of MENQUADFI."  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This report describes urticaria in a 5 y.o. vaccinee of unspecified gender who received Havrix vax. Medical history, concurrent conditions, and concurrent medications were not specified. The vaccinee had not experienced adverse events following previous vax's. On an unspecified date, the vaccinee received the first injection of Havrix. That evening, the vaccinee experienced a fever of 102 deg F. Rash and urticaria developed later. The reporter stated that the events were possibly related to Havrix. As of 3/21/02, the adverse events had resolved.
On March 30th I started getting headaches.  They would evolve into intense, debilitating headaches where I could not function and had to go to bed.  Generally they would start early afternoon and by 4pm I was incapacitated.  The intensity would last for hours and then settle down to just a throbbing.  I have never experienced anything like this.   On April 7th I saw a primary care doctor who prescribed a 7 day dose of methylprednisolone.  The headaches subsided around April 11th. PLEASE NOTE: I had the J&J one shot COVID 19 vaccine on March 8th
Client stated started to feel lightheaded after vaccination. BP 123/75, HR 84, O2 Sat 97% At 10:40 am stated felt much better, left observation area.
Seizure unilateral right side, less than 2 mins.   2 times post injection.
p/vax pt c/o inability to breathe-throat closing up 730PM hep lock started w/DPH & Decadron;
He was really really tired Tuesday through Friday; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177) as dose 1 single, administered in Deltoid Left on 24May2021 12:00 (at the age of 69-year-old) for COVID-19 immunization. Patient was diagnosed in 2011 or 2012 with antiphospholipid syndrome. The doctor that diagnosed him with Antiphospholipid syndrome earlier tested his blood, and the antibodies came back positive. He had surgery and was riding back and got a blood clot. An endocrinologist referred him and he found out he had antiphospholipid syndrome. The concomitant medications included apixaban (ELIQUIS) and testosterone (TESTOSTERONE). Because of patient condition, an auto immune disease that affects clotting, he takes Eliquis. Prior to vaccination patient did not have any vaccines within 4 weeks. The patient experienced he was really really tired on 25May2021. He was really tired Tuesday through Friday. His energy levels really came back on Saturday, 29May2021 and he felt chipper. Outcome of the vent was recovered on 28May2021.  Information on Lot/Batch number was available. Additional information has been requested.   Follow-up attempts are completed. No further information is expected.
received THIRD Shingrix vaccine in error; This case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in July 2018). Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 5th November 2021, the patient received the 3rd dose of Shingrix (intramuscular). On 5th November 2021, unknown after receiving Shingrix and an unknown time after receiving SHINGRIX, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The reporter was the patient. The patient received 2nd dose of Shingrix in October 2018. The patient received 3rd dose of Shingrix in error in unknown arm, which led to extra dose administered. The reporter did not consent to follow up.
Symptoms have included mild to severe intermittent dizziness, chronic headaches, intense brain fog and forgetfulness, racing heart, random bouts of anxiety (anxiety attacks), lightheadedness, feelings of disassociation. All of the symptoms have come and gone in a cyclical pattern of acute adverse events, remission and relapse. These symptoms have been on and off for about 7 months. I've had no prior experience with any of these symptoms prior to the vaccines.
CHILD'S DATE OF BIRTH WRITTEN AS 1/12/2009 AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY PERSON IDENTIFYING AS MOM. CHILD IDENTIFIED IN IMMUNIZATION REGISTRY WITH DATE OF BIRTH AS 1/12/2010.  MAY BE CONFUSED WITH ANOTHER FILE NUMBER IN IMMUNIZATION REGISTRY??
A significant amount of vaccine popped out of my arm. Do not know how much medicine I received. Any advice? Please help.
This spontaneous report has been received from a nurse practitioner referring to an unspecified number of patients of unknown age and gender. The patients' medical history, drug reactions, concomitant therapies or allergies were not provided. On an unknown date, the patient were vaccinated with an improperly stored dose of VARIVAX, (route of administration, dose, and anatomical location were not provided) lot # L011082, expiration date 01-APR-2017. No adverse event was reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
On 3/16/21 at approximately 12PM a middle-aged male patient came in to get his first dose of Moderna vaccine. I took in this patient into the IMZ room to give his vaccination and reviewed his form he filled out. On the question related to "have you ever had a reaction to a vaccine (fainting/dizzy)" the patient answered "No". The patient walked outside to the waiting area and sat down to begin his 15mins, at that point another customer yelled for medical attention for him because he passed out in the chair. I ran out with an EpiPen in case it was anaphylaxis. After I got outside the patient regained consciousness in the matter of seconds but was still dazed/confused and I applied a cold compress to the back of his neck and gave the patient some water to drink while feeling for his pulse in the wrist. He began to lose his color/pallor in his face again for a second time at that point I told my technician to call 911, after we dialed them, the patient came back to fully again this time and all color was restored to his face and he was fully conscious this time and able to speak in complete sentences. He wanted me to cancel the 911 call and since he came back to consciousness again in the matter of seconds so we canceled it. I made the patient wait an extra 30 minutes to observe him and he was fine from there on out, his wife was accompanying him and stated he has done this in the past for vaccines (despite answering no in the assessment form) and said she will be driving him home and checking in with his doctor later.
States the patient never received the second dose and it has now been "4 months" since first dose was administered.; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (States the patient never received the second dose and it has now been "4 months" since first dose was administered.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced PRODUCT DOSE OMISSION ISSUE (States the patient never received the second dose and it has now been "4 months" since first dose was administered.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (States the patient never received the second dose and it has now been "4 months" since first dose was administered.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non significant follow up On 25-May-2021: Non significant follow up accepted on 27-05-21 On 26-May-2021: Received 2nd dose after 3 months, no AE
- sharp intestinal colicky pain - abdominal pain/cramps - pain at injection site (left arm), left armpit and left side of the chest - muscle/join aches - mild fever
This case was reported by a consumer and described the occurrence of shingles in a 53-year-old female patient who received SHINGRIX for prophylaxis. In May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information received as follows: The age at vaccination was not reported, but the patient was 53 years old at the reporting time. The patient never had shingles until the 1st dose of SHINGRIX. The shingles was mild and on the patient's forehead and face. The second dose of SHINGRIX which was scheduled on 1st November 2018. Since the patient had an outbreak at the time of reporting, she asked if she could keep the 2nd dose scheduled if the adverse event had not cleared up by then and if not did she have to start over with the first dose again. The patient reported that her physician did not leave her with much confidence in his knowledge of the vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION HCL, start date: 10May2023. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin", notes: Known allergies: Erythromycin. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 as Paxlovid from 08Oct2023 to 12Oct2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300336079 same reporter/patient with different drug/AE;
Information has been received from a physician and a Registered Nurse concerning a 18 year old (also reported as 19 year old) female patient with well controlled juvenile seizures/seizure disorder since childhood and anxiety/depression who on 19-JAN-2012, was vaccinated with the first dose of GARDASIL, 0.5 ml, IM (site of administration not reported, lot number 672232/1495AA). Concomitant therapy included PROZAC, LAMICTAL and LO/OVRAL. It was reported that the patient had two mini seizures between 19-JAN-2012 and 21-MAR-2012 and the seizures were under control at time of gynecological visit. The two mini seizures were experienced at home, no treatment was necessary, in fact the patient did not see her neurologist about them. If the neurologist would give the written approval, the GARDASIL series would continue. It was reported that the therapy was not discontinued. At the time of the report the patient recovered. Upon internal review, mini seizures were determined to be an other important medical event. NO further information is available.
passed out; syncope / syncopal episode; This spontaneous report was received from a physician via a company representative and refers to a 17-year-old female patient. The patient had none pertinent medical history or concomitant medications and there were no drug reactions or allergies known.  On approximately 08-JAN-2020 (reported as three weeks ago), the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, exact dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On the same day, the patient was vaccinated with three other unspecified vaccines.  On the same day, after receipt of the vaccines, the patient passed out, experiencing syncope. Syncopal episode resolved and the patient went home the same day. The patient did not seek medical attention and received no treatment for the events. None lab diagnostics or studies were performed.  The relatedness between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.  Upon internal review, the events of passed out and syncope were considered to be medically significant.
I tested positive for Covid-19 on January 8, 2023 I experienced a scratchy throat, fever, mild congestion. I was prescribed Paxlovid for my symptoms after 2-3 weeks my congestion gotten worse. Then one morning I was showering and passed out. I had a cough and my blood pressure a little low with a white high blood count. I was prescribed an antibiotic for those symptoms.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 15-NOV-2011, the patient was vaccinated at physician office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 12-MAR-2016, the patient was treated for blistering vesicular outbreaks that were diagnosed as severe shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient ran fever, extremely fussy, not sleeping, general malaise, and developed a rash after 10 days.
Felt dizzy, and couldn't breathe/catch my breath for a minute; collapsed but did not faint or lose consciousness
Pt given immunization on 3/13/03. Mom brought pt back to clinic on 3/4/03 fir adverse rxn to immunization. 11X13cm, red, swollen, and warm to touch area to L thigh. Pt given Zyrtec 1 tsp. daily and motrin.